Skip to content

The Study of Sleep Disordered Breathing in Patients With Interstitial Lung Diseases

Study of the Prevalence and Predictive Factors of Sleep Disordered Breathing in Patients With Interstitial Lung Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06012526
Enrollment
69
Registered
2023-08-25
Start date
2020-11-25
Completion date
2022-07-24
Last updated
2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea-hypopnea

Brief summary

This was a cross-sectional observational study to evaluate the prevalence and predictive factors of SDB in ILD and to analyze the relationship between polysomnography (PSG) findings, pulmonary function, disease severity, parenchymal involvement, and sleep questionnaires ESS and SBQ. This study included 69 patients who were diagnosed with diffuse parenchymal lung diseases by high-resolution computed tomography (HRCT) chest. All patients were subjected to clinical examination, HRCT, spirometry, full-night polysomnography, and echocardiography.

Interventions

DIAGNOSTIC_TESTPolysomnography

Polysomnography is done for patients to find any sleep disordered breathing

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Both sexes of clinically stable ILD patients older than 18 who met the ATS/ERS criteria for an ILD diagnosis were included in the study.

Exclusion criteria

* Patients who have any anatomic upper airway obstructions such as significant nasal septal deviation, nasal polyps, conchae hypertrophy or tonsillar hypertrophy. * Patients with neurological diseases or severe psychiatric disorders. * Patients who have history of administration of any drug that has a major effect on sleep e.g. benzodiazepine, narcotic drugs ….etc. * Patients with any chronic pulmonary disease except ILD. * Total sleep time less than 4 hours on PSG.

Design outcomes

Primary

MeasureTime frameDescription
Measurements of apnea hypopnea index1and half yearsPolysomnography can measure apnea hypopnea index of all patients to detect sleep disordered breathing

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026